Media Outlets Report on Addition of Former Rep. Ed Perlmutter to NCR Policy Leadership Team
Read full coverage from MMJ Daily, Cannabis Business Times, Green Market Report, Marijuana Moment, and Cannabis Wire.
Read full coverage from MMJ Daily, Cannabis Business Times, Green Market Report, Marijuana Moment, and Cannabis Wire.
FOR IMMEDIATE RELEASE February 1, 2024 CONTACT: Erin@TheLiaisonGroup.com NATIONAL CANNABIS ROUNDTABLE ANNOUNCES ADDITION OF SAFE CHAMPION AND FORMER CONGRESSMAN ED PERLMUTTER TO FEDERAL POLICY LEADERSHIP TEAM Washington, D.C. – The National Cannabis Roundtable (NCR) announced today the addition of former Congressman Ed Perlmutter (D-CO) to its deep bench of respected federal policy
Read full coverage from Cannabis Business Times, MMJ Daily, Politico Pro, and Cannabis Wire.
FOR IMMEDIATE RELEASE January 30, 2024 CONTACT: Erin@TheLiaisonGroup.com NATIONAL CANNABIS ROUNDTABLE CONTINUES GROWTH IN NEW YEAR, WELCOMES NEW MEMBERS Washington, D.C. – Today, the National Cannabis Roundtable (NCR) is proud to announce the addition of Ascend Wellness Holdings, Proper Brands, and Verano to its membership. These three new NCR members bring a
NCR\’s Executive Director Saphira Galoob, Director of Policy David Mangone, and Director of Communications and Policy Advisor Erin Moffet sat down with Karson Humiston for an interview for an episode of the Vangst podcast, \”Proud to Work in Cannabis.\” You can find this here, or wherever you listen to podcasts.
NCR Interviewed for Vangst Podcast, \”Proud to Work in Cannabis\” Read More »
Several organizations and cannabis companies sent statements to High Times. The National Cannabis Roundtable (NCR) applauded the historic acknowledgement that a federal agency has recommended cannabis be reclassified. The NCR announced that they have been instrumental in advocating for and informing the heads of the HHS in a memo, and the DEA in an open letter, as to the scientific
“The importance of a federal agency publicly acknowledging that cannabis is inappropriately classified as a Schedule I substance and has accepted medical use cannot be overstated,” said Saphira Galoob, Executive Director of the National Cannabis Roundtable, in a press release. Read full coverage here.
FOR IMMEDIATE RELEASE January 12, 2024 CONTACT: Erin@TheLiaisonGroup.com NATIONAL CANNABIS ROUNDTABLE APPLAUDS HISTORIC HHS RECOMMENDATION TO RESCHEDULE CANNABIS Washington, D.C. – Following the release of documents from the U.S. Department of Health and Human Services earlier today relating to the agency’s review of the federal classification of cannabis, the National Cannabis Roundtable (NCR)